Marketing-authorisation holder Β· Canada
Apotex Inc
1,382 medicines in 1 country, as authorisation holder.
Loading your pageβ¦
Marketing-authorisation holder Β· Canada
1,382 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1β25 of 1,382
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 24HR NASAL ALLERGY RELIEF50 mcg / act Β· Spray (Metered-Dose) | Fluticasone | Canada | Marketed | 2017 |
| ACETAMINOPHEN CAPLETS 325 MG325 mg Β· Tablet | Paracetamol | Canada | Marketed | 2011 |
| ACETAMINOPHEN CAPLETS 500 MG500 mg Β· Tablet | Paracetamol | Canada | Marketed | 2011 |
| ACETAMINOPHEN/DEXTROMETHORPHAN/PSEUDOEPHEDRINE325 mg + 15 mg + 30 mg Β· Capsule | Paracetamol, Dextromethorphan, Pseudoephedrine | Canada | Authorised | |
| ACETAMINOPHEN EASY SWALLOW500.0 mg Β· Tablet | Paracetamol | Canada | Authorised | |
| ACETAMINOPHEN HEADACHE ULTRA RELIEF500 mg + 65 mg Β· Tablet | Paracetamol, Caffeine | Canada | Not marketed | 2008 |
| ACETAMINOPHEN LIQUID GEL CAPSULES325 mg Β· Capsule | Paracetamol | Canada | Not marketed | 2017 |
| ACETAMINOPHEN/PSEUDOEPHEDRINE/DEXTROMETHORPHAN/DOXYLAMINE325 mg + 15 mg + 6.25 mg + 30 mg Β· Capsule | Paracetamol, Dextromethorphan, Doxylamine, Pseudoephedrine | Canada | Authorised | |
| ACETAMINOPHEN TABLETS USP 325 MG325 mg Β· Tablet | Paracetamol | Canada | Marketed | 2011 |
| ACETAMINOPHEN TABLETS USP 500 MG500 mg Β· Tablet | Paracetamol | Canada | Marketed | 2011 |
| ACID CONTROL10 mg Β· Tablet | Famotidine | Canada | Not marketed | 2000 |
| ACID CONTROL20 mg Β· Tablet | Famotidine | Canada | Not marketed | 2014 |
| ACID REDUCER150 mg Β· Tablet | Ranitidine | Canada | Not marketed | 2014 |
| ACID REDUCER75 mg Β· Tablet | Ranitidine | Canada | Not marketed | 1999 |
| ACYCLOVIR200 mg Β· Tablet | Aciclovir | Canada | Authorised | 1996 |
| ACYCLOVIR800 mg Β· Tablet | Aciclovir | Canada | Authorised | 1996 |
| ACYCLOVIR400 mg Β· Tablet | Aciclovir | Canada | Authorised | 1996 |
| AFLIVU2 mg / 0.05 ml Β· Solution | Aflibercept | Canada | Marketed | 2025 |
| AFLIVU2 mg / 0.05 ml Β· Solution | Aflibercept | Canada | Marketed | 2025 |
| ALLER-RELIEF10 mg Β· Tablet | Cetirizine | Canada | Not marketed | 1999 |
| ALLERGY LIQUID GEL CAPSULES25 mg Β· Capsule | Diphenhydramine | Canada | Not marketed | 2016 |
| ALLERGY RELIEF10 mg Β· Tablet | Cetirizine | Canada | Marketed | 1999 |
| ALLERGY RELIEF LIQUID GELS10 mg Β· Capsule | Cetirizine | Canada | Not marketed | 2015 |
| ALLERGY RELIEF NASAL SPRAY50 mcg / act Β· Spray (Metered-Dose) | Fluticasone | Canada | Authorised | |
| ALLERGY REMEDY10 mg Β· Tablet | Loratadine | Canada | Marketed | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 1,382 | 1,207 | 175 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.